Latest Investor Confidence News

Orion Minerals advances its Definitive Feasibility Studies for the Flat Mines and Prieska Copper Zinc projects, with independent reviews underway and production targeted for 2026.

Estrella Resources has secured $3.75 million through a share placement to fund its upcoming drilling program in Timor-Leste, signaling renewed momentum in its exploration efforts.

Native Mineral Resources has secured key Queensland gold assets and is advancing refurbishment of the Blackjack Processing Plant, targeting production restart by Q3 2025. The company’s recent capital raises underpin its ambitious development plans.

Everest Metals Corporation is issuing $720,000 in Junior Minerals Exploration Incentive credits to shareholders from its recent $2.4 million capital raising, offering a 30% effective tax credit on investments made during FY24.

Auric Mining Limited reports a robust cash flow quarter ending December 31, 2024, with current assets reaching approximately $10 million and ongoing cash inflows from its joint venture at Jeffreys Find Gold Mine.

My Rewards International Limited reports steady progress on its B2B rewards platform and the soft launch of its Klevo MasterCard, while navigating ongoing ASX suspension and securing a $15 million financing facility.

Leo Lithium Limited reports a robust cash position of $269.3 million following the sale of a 40% stake in MLBV, underpinning its financial strength amid ongoing operational expenditures.

Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.

Miramar Resources has responded to media reports about court proceedings involving its Executive Chairman Allan Kelly, clarifying the company is not involved and requesting the ASX lift the trading halt.

Infinity Mining has significantly broadened its exploration portfolio across Eastern Australia through key acquisitions and a $2 million capital raise, setting the stage for an active 2025 drilling campaign.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

InteliCare Holdings Limited reported a positive net cash flow of $30,000 for the December quarter, buoyed by a substantial government R&D rebate. The company ends the quarter with $1.26 million in cash, signaling operational stability amid ongoing funding evaluations.